+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Takeda Pharmaceutical Company Limited - logo

Takeda Pharmaceuticals is the largest pharmaceutical company in Asia and a top 15 pharmaceutical company in the world. It provides products in various therapeutic areas, including gastroenterology, oncology, central nervous system, cardiovascular and metabolic, vaccines, and others. Takeda was founded in 1781 and operates two primary bases in Japan in Osaka and Tokyo. Its global operations are based in Zurich, Switzerland.

Nivolumab Market Report 2025 - Product Thumbnail Image

Nivolumab Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Community-acquired Pneumonia (CAP) - Pipeline Insight, 2025 - Product Thumbnail Image

Community-acquired Pneumonia (CAP) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Schizophrenia Market Report 2025 - Product Thumbnail Image

Schizophrenia Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Psoriasis Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts ((2022 - 2027) - Product Thumbnail Image

Psoriasis Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts ((2022 - 2027)

  • Report
  • June 2022
  • 120 Pages
  • Global
From
Systemic Lupus Erythematosus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Systemic Lupus Erythematosus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 432 Pages
  • Global
From
Co-development Deals in Pharmaceuticals and Biotechnology 2016 to 2025 - Product Thumbnail Image

Co-development Deals in Pharmaceuticals and Biotechnology 2016 to 2025

  • Report
  • April 2025
  • 450 Pages
  • Global
From
Ulcerative Colitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Ulcerative Colitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • July 2022
  • 714 Pages
  • Global
From
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 79 Pages
  • Global
From
United States Hereditary Angioedema Therapeutics Market Report and Forecast 2024-2032 - Product Thumbnail Image

United States Hereditary Angioedema Therapeutics Market Report and Forecast 2024-2032

  • Report
  • August 2024
  • 160 Pages
  • United States
From
Osteoporosis Market Report and Forecast 2024-2032 - Product Thumbnail Image

Osteoporosis Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
Endometriosis Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Endometriosis Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • August 2024
  • 99 Pages
  • Global
From
Osteoporosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Osteoporosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 375 Pages
  • Global
From
Post Menopausal Osteoporosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Post Menopausal Osteoporosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 149 Pages
  • Global
From
Celiac Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Celiac Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • June 2022
  • 122 Pages
  • Global
From
Alzheimer's Disease Market (2nd edition) by Type of Treatment (Symptomatic and Disease Modifying), Symptomatic Indications (Dementia, Insomnia and Other Psychological Symptoms) and Geography (North America, Europe and Asia-Pacific), 2021-2030 - Product Thumbnail Image

Alzheimer's Disease Market (2nd edition) by Type of Treatment (Symptomatic and Disease Modifying), Symptomatic Indications (Dementia, Insomnia and Other Psychological Symptoms) and Geography (North America, Europe and Asia-Pacific), 2021-2030

  • Report
  • September 2021
  • 150 Pages
  • Global
From
Diabetic Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Diabetic Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • February 2024
  • 95 Pages
  • Global
From
Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2019-2025 - Product Thumbnail Image

Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2019-2025

  • Report
  • April 2025
  • 750 Pages
  • Global
From
Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2025 - Product Thumbnail Image

Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2025

  • Report
  • April 2025
  • 250 Days
  • Global
From
Non-insulin Diabetes Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Non-insulin Diabetes Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • February 2024
  • 118 Pages
  • Global
From
Multiple Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Multiple Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 696 Pages
  • Global
From
Loading Indicator